As evaluated in
IARC Monographs
Volumes 1-99
This list contains all agents evaluated as Group 3 carcinogens
to date.
Where appropriate, chemical abstract numbers are given [in
square brackets]. For details of the evaluation, the relevant
Monograph should be consulted (volume number given in round
brackets, followed by year of publication of latest evaluation).
Use a free-text search to find a particular compound.
Group 3: Not classifiable as to its carcinogenicity
to humans (515)
Agents and groups of agents
Acenaphthene [83-32-9] (Vol. 92; in preparation)
Acepyrene (3,4-dihydrocyclopenta[cd]pyrene) [25732-74-5]
(Vol. 92; in preparation)
Aciclovir [59277-89-3] (Vol. 76; 2000)
Acridine orange [494-38-2] (Vol. 16, Suppl. 7; 1987)
Acriflavinium chloride [8018-07-3] (Vol. 13, Suppl. 7;
1987)
Acrolein [107-02-8] (Vol. 63; 1995)
Acrylic acid [79-10-7] (Vol. 19, Suppl. 7, Vol. 71; 1999)
Acrylic fibres (Vol. 19, Suppl. 7; 1987)
Acrylonitrile-butadiene-styrene copolymers (Vol. 19,
Suppl. 7; 1987)
Actinomycin D [50-76-0] (Vol. 10, Suppl. 7; 1987)
Agaritine [2757-90-6] (Vol. 31, Suppl. 7; 1987)
Aldicarb [116-06-3] (Vol. 53; 1991)
Aldrin [309-00-2] (Vol. 5, Suppl. 7; 1987)
Allyl chloride [107-05-1] (Vol. 36, Suppl. 7, Vol. 71;
1999)
Allyl isothiocyanate [57-06-7] (Vol. 73; 1999)
Allyl isovalerate [2835-39-4] (Vol. 36, Suppl. 7, Vol.
71; 1999)
Amaranth [915-67-3] (Vol. 8, Suppl. 7; 1987)
5-Aminoacenaphthene [4657-93-6] (Vol. 16, Suppl. 7; 1987)
2-Aminoanthraquinone [117-79-3] (Vol. 27, Suppl. 7; 1987)
para-Aminobenzoic acid [150-13-0] (Vol. 16, Suppl.
7; 1987)
1-Amino-2-methylanthraquinone [82-28-0] (Vol. 27, Suppl.
7; 1987)
2-Amino-4-nitrophenol [99-57-0] (Vol. 57; 1993)
2-Amino-5-nitrophenol [121-88-0] (Vol. 57; 1993)
4-Amino-2-nitrophenol [119-34-6] (Vol. 16, Suppl. 7;
1987)
2-Amino-5-nitrothiazole [121-66-4] (Vol. 31, Suppl. 7;
1987)
11-Aminoundecanoic acid [2432-99-7] (Vol. 39, Suppl.
7; 1987)
Amitrole [61-82-5] (Vol. 79; 2001)
(NB: Overall evaluation downgraded from 2B to 3 with supporting
evidence from other relevant data)
Ampicillin [69-53-4] (Vol. 50; 1990)
Anaesthetics, volatile (Vol. 11, Suppl. 7; 1987)
Angelicin [523-50-2] plus ultraviolet A radiation (Vol.
40, Suppl. 7; 1987)
Aniline [62-53-3] (Vol. 27, Suppl. 7; 1987)
para-Anisidine [104-94-9] (Vol. 27, Suppl. 7;
1987)
Anthanthrene [191-26-4] (Vol. 32, Suppl. 7, Vol. 92;
in preparation)
Anthracene [120-12-7] (Vol. 32, Suppl. 7, Vol. 92; in
preparation)
Anthranilic acid [118-92-3] (Vol. 16, Suppl. 7; 1987)
Antimony trisulfide [1345-04-6] (Vol. 47; 1989)
Apholate [52-46-0] (Vol. 9, Suppl. 7; 1987)
para-Aramid fibrils [24938-64-5] (Vol. 68; 1997)
Atrazine [1912-24-9] (Vol. 73; 1999)
(NB: Overall evaluation downgraded from 2B to 3 with supporting
evidence from other relevant data)
Aurothioglucose [12192-57-3] (Vol. 13, Suppl. 7; 1987)
2-(1-Aziridinyl)ethanol [1072-52-2] (Vol. 9, Suppl. 7;
1987)
Aziridyl benzoquinone [800-24-8] (Vol. 9, Suppl. 7; 1987)
Azobenzene [103-33-3] (Vol. 8, Suppl. 7; 1987)
11H-Benz[bc]aceanthrylene [202-94-8] (Vol.
92; in preparation)
Benz[l]aceanthrylene [211-91-6] (Vol. 92; in preparation)
Benz[a]acridine [225-11-6] (Vol. 32, Suppl. 7;
1987)
Benz[c]acridine [225-51-4] (Vol. 32, Suppl. 7;
1987)
Benzo[b]chrysene [214-17-5] (Vol. 92; in preparation)
Benzo[g]chrysene [196-78-1] (Vol. 92; in preparation)
Benzo[a]fluoranthene [203-33-8] (Vol. 92; in preparation)
Benzo[ghi]fluoranthene [203-12-3] (Vol. 32, Suppl.
7, Vol. 92; in preparation)
Benzo[a]fluorene [238-84-6] (Vol. 32, Suppl. 7,
Vol. 92; in preparation)
Benzo[b]fluorene [243-17-4] (Vol. 32, Suppl. 7,
Vol. 92; in preparation)
Benzo[c]fluorene [205-12-9] (Vol. 32, Suppl. 7,
Vol. 92; in preparation)
Benzo[ghi]perylene [191-24-2] (Vol. 32, Suppl.
7, Vol. 92; in preparation)
Benzo[e]pyrene [192-97-2] (Vol. 32, Suppl. 7,
Vol. 92; in preparation)
para-Benzoquinone dioxime [105-11-3] (Vol. 29,
Suppl. 7, Vol. 71; 1999)
Benzoyl peroxide [94-36-0] (Vol. 36, Suppl. 7, Vol. 71;
1999)
Benzyl acetate [140-11-4] (Vol. 40, Suppl. 7, Vol. 71;
1999)
Bis(1-aziridinyl)morpholinophosphine sulfide [2168-68-5]
(Vol.9, Suppl. 7; 1987)
Bis(2-chloroethyl)ether [111-44-4] (Vol. 9, Suppl. 7,
Vol. 71; 1999)
1,2-Bis(chloromethoxy)ethane [13483-18-6] (Vol. 15; Suppl.
7, Vol. 71; 1999)
1,4-Bis(chloromethoxymethyl)benzene [56894-91-8] (Vol.
15, Suppl. 7, Vol. 71; 1999)
Bis(2-chloro-1-methylethyl)ether [108-60-1] (Vol. 41,
Suppl. 7, Vol. 71; 1999)
Bis(2,3-epoxycyclopentyl)ether [2386-90-5] (Vol. 47,
Vol. 71; 1999)
Bisphenol A diglycidyl ether (Aralditeâ)
[1675-54-3] (Vol. 47, Vol. 71; 1999)
Bisulfites (Vol. 54; 1992)
Blue VRS [129-17-9] (Vol. 16, Suppl. 7; 1987)
Brilliant Blue FCF, disodium salt [3844-45-9] (Vol. 16,
Suppl.7; 1987)
Bromochloroacetonitrile [83463-62-1] (Vol. 52, Vol. 71;
1999)
Bromoethane [74-96-4] (Vol. 52, Vol. 71; 1999)
Bromoform [75-25-2] (Vol. 52, Vol. 71; 1999)
2-Butoxyethanol [111-76-2] (Vol. 88; 2006)
1-tert-Butoxypropan-2-ol
[57018-52-7] (Vol. 88; 2006)
n-Butyl acrylate [141-32-2] (Vol. 39, Suppl. 7,
Vol. 71; 1999)
Butylated hydroxytoluene (BHT) [128-37-0] (Vol. 40, Suppl.
7; 1987)
Butyl benzyl phthalate [85-68-7] (Vol. 73; 1999)
g-Butyrolactone [96-48-0]
(Vol. 11, Suppl. 7, Vol. 71; 1999)
Caffeine [58-08-2] (Vol. 51; 1991)
Cantharidin [56-25-7] (Vol. 10, Suppl. 7; 1987)
Captan [133-06-2] (Vol. 30, Suppl. 7; 1987)
Carbaryl [63-25-2] (Vol. 12, Suppl. 7; 1987)
Carbazole [86-74-8] (Vol. 32, Suppl. 7, Vol. 71; 1999)
3-Carbethoxypsoralen [20073-24-9] (Vol. 40, Suppl. 7;
1987)
Carmoisine [3567-69-9] (Vol. 8, Suppl. 7; 1987)
Carrageenan [9000-07-1], native (Vol. 31, Suppl. 7; 1987)
Chloral [75-87-6] (Vol. 63; 1995)
Chloral hydrate [302-17-0] (Vol. 84; 2004)
Chloramine [10599-90-3] (Vol. 84; 2004)
Chlordimeform [6164-98-3] (Vol. 30, Suppl. 7; 1987)
Chlorinated drinking-water (Vol. 52; 1991)
Chloroacetonitrile [107-14-2] (Vol. 52, Vol. 71; 1999)
Chlorobenzilate [510-15-6] (Vol. 30, Suppl. 7; 1987)
Chlorodibromomethane [124-48-1] (Vol. 52, Vol. 71; 1999)
Chlorodifluoromethane [75-45-6] (Vol. 41, Suppl. 7, Vol.
71; 1999)
Chloroethane [75-00-3] (Vol. 52, Vol. 71; 1999)
Chlorofluoromethane [593-70-4] (Vol. 41, Suppl. 7, Vol.
71; 1999)
3-Chloro-2-methylpropene [563-47-3] (Vol. 63; 1995)
4-Chloro-meta-phenylenediamine [5131-60-2] (Vol.
27, Suppl.7; 1987)
Chloronitrobenzenes [88-73-3; 121-73-3; 100-00-5] (Vol.
65; 1996)
Chloropropham [101-21-3] (Vol. 12, Suppl. 7; 1987)
Chloroquine [54-05-7] (Vol. 13, Suppl. 7; 1987)
5-Chloro-ortho-toluidine [95-79-4] (Vol. 77; 2000)
2-Chloro-1,1,1-trifluoroethane [75-88-7] (Vol. 41, Suppl.
7, Vol. 71; 1999)
Cholesterol [57-88-5] (Vol. 31, Suppl. 7; 1987)
Chromium[III] compounds (Vol. 49; 1990)
Chromium [7440-47-3], metallic (Vol. 49; 1990)
Chrysoidine [532-82-1] (Vol. 8, Suppl. 7; 1987)
CI Acid Orange 3 [6373-74-6] (Vol. 57; 1993)
Cimetidine [51481-61-9] (Vol. 50; 1990)
Cinnamyl anthranilate [87-29-6] (Vol. 77; 2000)
CI Pigment Red 3 [2425-85-6] (Vol. 57; 1993)
Citrinin [518-75-2] (Vol. 40, Suppl. 7; 1987)
Clofibrate [637-07-0] (Vol. 66; 1996)
Clomiphene citrate [50-41-9] (Vol. 21, Suppl. 7; 1987)
Coal dust (Vol. 68; 1997)
Continuous glass filament (Vol. 43, Vol. 81; 2002)
Copper 8-hydroxyquinoline [10380-28-6] (Vol. 15, Suppl.
7; 1987)
Coronene [191-07-1] (Vol. 32, Suppl. 7; 1987)
Coumarin [91-64-5] (Vol. 77; 2000)
meta-Cresidine [102-50-1] (Vol. 27, Suppl. 7;
1987)
Crotonaldehyde [4170-30-3] (Vol. 63; 1995)
Cyclamates [sodium cyclamate, 139-05-9] (Vol. 73; 1999)
Cyclochlorotine [12663-46-6] (Vol. 10, Suppl. 7; 1987)
Cyclohexanone [108-94-1] (Vol. 47, Vol. 71; 1999)
4H-Cyclopenta[def]chrysene [202-98-2] (Vol.
92; in preparation)
5,6-Cyclopenteno-1,2-benzanthracene [7099-43-6] (Vol.
92; in preparation)
D & C Red No. 9 [5160-02-1] (Vol. 57; 1993)
Dapsone [80-08-0] (Vol. 24, Suppl. 7; 1987)
Decabromodiphenyl oxide [1163-19-5] (Vol. 48, Vol. 71;
1999)
Deltamethrin [52918-63-5] (Vol. 53; 1991)
Diacetylaminoazotoluene [83-63-6] (Vol. 8, Suppl. 7;
1987)
Diallate [2303-16-4] (Vol. 30, Suppl. 7; 1987)
1,2-Diamino-4-nitrobenzene [99-56-9] (Vol. 16, Suppl.
7; 1987)
1,4-Diamino-2-nitrobenzene [5307-14-2] (Vol. 57; 1993)
2,5-Diaminotoluene [95-70-5] (Vol. 16, Suppl. 7; 1987)
Diazepam [439-14-5] (Vol. 66; 1996)
Diazomethane [334-88-3] (Vol. 7, Suppl. 7; 1987)
Dibenz[a,c]anthracene [215-58-7] (Vol. 32, Suppl.
7, Vol. 92; in preparation)
Dibenz[a,j]anthracene [224-41-9] (Vol. 32, Suppl.
7, Vol. 92; in preparation)
Dibenzo-para-dioxin (Vol. 69; 1997)
Dibenzo[a,e]fluoranthene [5385-75-1] (Vol. 32,
Suppl. 7, Vol. 92; in preparation)
13H-Dibenzo[a,g]fluorene [207-83-0]
(Vol. 92; in preparation)
Dibenzo[h,rst]pentaphene [192-47-2] (Vol. 3, Suppl.
7, Vol. 92; in preparation)
Dibenzo[a,e]pyrene [192-65-4] (Vol. 32,
Suppl. 7, Vol. 92; in preparation)
Dibenzo[e,l]pyrene [192-51-8] (Vol. 92;
in preparation)
Dibromoacetonitrile [3252-43-5] (Vol. 52, Vol. 71; 1999)
Dichloroacetonitrile [3018-12-0] (Vol. 52, Vol. 71; 1999)
Dichloroacetylene [7572-29-4] (Vol. 39, Suppl. 7, Vol.
71; 1999)
meta-Dichlorobenzene [541-73-1] (Vol. 73; 1999)
ortho-Dichlorobenzene [95-50-1] (Vol. 73; 1999)
trans-1,4-Dichlorobutene [110-57-6] (Vol. 15,
Suppl. 7, Vol. 71; 1999)
2,6-Dichloro-para-phenylenediamine [609-20-1]
(Vol. 39, Suppl. 7; 1987)
1,2-Dichloropropane [78-87-5] (Vol. 41, Suppl. 7, Vol.
71; 1999)
Dicofol [115-32-2] (Vol. 30, Suppl. 7; 1987)
Didanosine [69655-05-6] (Vol. 76; 2000)
Dieldrin [60-57-1] (Vol. 5, Suppl. 7; 1987)
Diethanolamine [111-42-2] (Vol. 77; 2000)
Di(2-ethylhexyl) adipate [103-23-1] (Vol. 77; 2000)
Di(2-ethylhexyl) phthalate [117-81-7] (Vol. 77; 2000)
(NB: Overall evaluation downgraded from 2B to 3 with supporting
evidence from other relevant data)
N,N'-Diethylthiourea [105-55-5] (Vol. 79;
2001)
Dihydroaceanthrylene [641-48-5] (Vol. 92; in preparation)
Dihydroxymethylfuratrizine [794-93-4] (Vol. 24, Suppl.
7; 1987)
Dimethoxane [828-00-2] (Vol. 15, Suppl. 7; 1987)
3,3'-Dimethoxybenzidine-4,4'-diisocyanate [91-93-0] (Vol.
39, Suppl. 7; 1987)
para-Dimethylaminoazobenzenediazo sodium sulfonate
[140-56-7] (Vol. 8, Suppl. 7; 1987)
4,4'-Dimethylangelicin [22975-76-4] plus ultraviolet
A radiation (Suppl. 7; 1987)
4,5'-Dimethylangelicin [4063-41-6] plus ultraviolet A
radiation (Suppl. 7; 1987)
N,N-Dimethylaniline [121-69-7] (Vol. 57;
1993)
Dimethylformamide [68-12-2] (Vol. 47; Vol. 71; 1999)
Dimethyl hydrogen phosphite [868-85-9] (Vol. 48, Vol.
71; 1999)
1,4-Dimethylphenanthrene [22349-59-3] (Vol. 32, Suppl.
7, Vol. 92; in preparation)
1,3-Dinitropyrene [75321-20-9] (Vol. 46; 1989)
3,5-Dinitrotoluene [618-85-9] (Vol. 65; 1996)
Dinitrosopentamethylenetetramine [101-25-7] (Vol. 11,
Suppl. 7; 1987)
2,4'-Diphenyldiamine [492-17-1] (Vol. 16, Suppl. 7; 1987)
Disperse Yellow 3 [2832-40-8] (Vol. 48; 1990)
Disulfiram [97-77-8] (Vol. 12, Suppl. 7; 1987)
Dithranol [1143-38-0] (Vol. 13; Suppl. 7; 1987)
Doxefazepam [40762-15-0] (Vol. 66; 1996)
Doxylamine succinate [562-10-7] (Vol. 79; 2001)
Droloxifene [82413-20-5] (Vol. 66; 1996)
Dulcin [150-69-6] (Vol. 12, Suppl. 7; 1987)
Electric fields (extremely low-frequency) (Vol. 80; 2002)
Electric fields (static) (Vol. 80; 2002)
Endrin [72-20-8] (Vol. 5, Suppl. 7; 1987)
Eosin [15086-94-9] (Vol. 15, Suppl. 7; 1987)
3,4-Epoxy-6-methylcyclohexylmethyl-3,4-epoxy-6-methylcyclo-hexanecarboxylate
[141-37-7]
(Vol. 11, Suppl. 7, Vol. 71; 1999)
cis-9,10-Epoxystearic acid [2443-39-2] (Vol. 11,
Suppl. 7, Vol. 71; 1999)
Estazolam [29975-16-4] (Vol. 66; 1996)
Ethionamide [536-33-4] (Vol. 13, Suppl. 7; 1987)
Ethylene [74-85-1] (Vol. 60; 1994)
Ethylene sulfide [420-12-2] (Vol. 11, Suppl. 7; 1987)
Ethylenethiourea [96-45-7] (Vol. 79; 2001)
(NB: Overall evaluation downgraded from 2B to 3 with supporting
evidence from other relevant data)
2-Ethylhexyl acrylate [103-11-7] (Vol. 60; 1994)
Ethyl selenac [5456-28-0] (Vol. 12, Suppl. 7; 1987)
Ethyl tellurac [20941-65-5] (Vol. 12, Suppl. 7; 1987)
Eugenol [97-53-0] (Vol. 36, Suppl. 7; 1987)
Evans blue [314-13-6] (Vol. 8, Suppl. 7; 1987)
Fast Green FCF [2353-45-9] (Vol. 16, Suppl. 7; 1987)
Fenvalerate [51630-58-1] (Vol. 53; 1991)
Ferbam [14484-64-1] (Vol. 12, Suppl. 7; 1987)
Ferric oxide [1309-37-1] (Vol. 1, Suppl. 7; 1987)
Fluometuron [2164-17-2] (Vol. 30, Suppl. 7; 1987)
Fluoranthene [206-44-0] (Vol. 32, Suppl. 7, Vol. 92;
in preparation)
Fluorene [86-73-7] (Vol. 32, Suppl. 7, Vol. 92; in preparation)
Fluorescent lighting (Vol. 55; 1992)
Fluorides (inorganic, used in drinking-water) (Vol. 27,
Suppl.7; 1987)
5-Fluorouracil [51-21-8] (Vol. 26, Suppl. 7; 1987)
[Foreign bodies: see Surgical implants and other foreign
bodies]
Furazolidone [67-45-8] (Vol. 31, Suppl. 7; 1987)
Furfural [98-01-1] (Vol. 63; 1995)
Furosemide (Frusemide) [54-31-9] (Vol. 50; 1990)
Gemfibrozil [25812-30-0] (Vol. 66; 1996)
Glycidyl oleate [5431-33-4] (Vol. 11, Suppl. 7; 1987)
Glycidyl stearate [7460-84-6] (Vol. 11, Suppl. 7; 1987)
Guinea Green B [4680-78-8] (Vol. 16, Suppl. 7; 1987)
Gyromitrin [16568-02-8] (Vol. 31, Suppl. 7; 1987)
Haematite [1317-60-8] (Vol. 1, Suppl. 7; 1987)
HC Blue No. 2 [33229-34-4] (Vol. 57; 1993)
HC Red No. 3 [2871-01-4] (Vol. 57; 1993)
HC Yellow No. 4 [59820-43-8] (Vol. 57; 1993)
Hepatitis D virus (Vol. 59; 1994)
Hexachlorobutadiene [87-68-3] (Vol. 73; 1999)
Hexachlorophene [70-30-4] (Vol. 20, Suppl. 7; 1987)
Human T-cell lymphotropic virus type II (Vol. 67; 1996)
Hycanthone mesylate [23255-93-8] (Vol. 13, Suppl. 7;
1987)
Hydralazine [86-54-4] (Vol. 24, Suppl. 7; 1987)
Hydrochloric acid [7647-01-0] (Vol. 54; 1992)
Hydrochlorothiazide [58-93-5] (Vol. 50; 1990)
Hydrogen peroxide [7722-84-1] (Vol. 36, Suppl. 7, Vol.
71; 1999)
Hydroquinone [123-31-9] (Vol. 15, Suppl. 7, Vol. 71;
1999)
4-Hydroxyazobenzene [1689-82-3] (Vol. 8, Suppl. 7; 1987)
8-Hydroxyquinoline [148-24-3] (Vol. 13, Suppl. 7; 1987)
Hydroxysenkirkine [26782-43-4] (Vol. 10, Suppl. 7; 1987)
Hydroxyurea [127-07-1] (Vol. 76; 2000)
Hypochlorite salts (Vol. 52; 1991)
Insulation glass wool (Vol. 43, Vol. 81; 2002)
Iron-dextrin complex [9004-51-7] (Vol. 2, Suppl. 7; 1987)
Iron sorbitol-citric acid complex [1338-16-5] (Vol. 2,
Suppl. 7; 1987)
Isatidine [15503-86-3] (Vol. 10, Suppl. 7; 1987)
Isonicotinic acid hydrazide (Isoniazid) [54-85-3] (Vol.
4, Suppl.7; 1987)
Isophosphamide [3778-73-2] (Vol. 26, Suppl. 7; 1987)
Isopropanol [67-63-0] (Vol. 15, Suppl. 7, Vol. 71; 1999)
Isopropyl oils (Vol. 15, Suppl. 7, Vol. 71; 1999)
Isosafrole [120-58-1] (Vol. 10, Suppl. 7; 1987)
Jacobine [6870-67-3] (Vol. 10, Suppl. 7; 1987)
Kaempferol [520-18-3] (Vol. 31, Suppl. 7; 1987)
Kojic acid [501-30-4] (Vol. 79; 2001)
Lauroyl peroxide [105-74-8] (Vol. 36, Suppl. 7, Vol.
71; 1999)
Lead compounds, organic (Vol. 23, Suppl. 7, Vol. 87;
2006)
(NB: Organic lead compounds are metabolized, at least
in part, to ionic lead both in humans and animals. To
the extent that ionic lead, generated from organic lead,
is present in the body, it will be expected to exert the
toxicities associated with inorganic lead.)
Light Green SF [5141-20-8] (Vol. 16, Suppl. 7; 1987)
d-Limonene [5989-27-5] (Vol. 73; 1999)
(NB: Overall evaluation downgraded from 2B to 3 with supporting
evidence from other relevant data)
Luteoskyrin [21884-44-6] (Vol. 10, Suppl. 7; 1987)
Madder root (Rubia tinctorum) (Vol. 82; 2002)
Magnetic fields (static) (Vol. 80; 2002)
Malathion [121-75-5] (Vol. 30, Suppl. 7; 1987)
Maleic hydrazide [123-33-1] (Vol. 4, Suppl. 7; 1987)
Malonaldehyde [542-78-9] (Vol. 36, Suppl. 7, Vol. 71;
1999)
Maneb [12427-38-2] (Vol. 12, Suppl. 7; 1987)
Mannomustine dihydrochloride [551-74-6] (Vol. 9, Suppl.
7; 1987)
Medphalan [13045-94-8] (Vol. 9, Suppl. 7; 1987)
Melamine [108-78-1] (Vol. 73; 1999)
(NB: Overall evaluation downgraded from 2B to 3 with supporting
evidence from other relevant data)
6-Mercaptopurine [50-44-2] (Vol. 26, Suppl. 7; 1987)
Mercury [7439-97-6] and inorganic mercury compounds (Vol.
58; 1993)
Metabisulfites (Vol. 54; 1992)
Methimazole [60-56-0] (Vol. 79; 2001)
Methotrexate [59-05-2] (Vol. 26, Suppl. 7; 1987)
Methoxychlor [72-43-5] (Vol. 20, Suppl. 7; 1987)
Methyl acrylate [96-33-3] (Vol. 39, Suppl. 7, Vol. 71;
1999)
5-Methylangelicin [73459-03-7] plus ultraviolet A radiation
(Suppl.7; 1987)
Methyl bromide [74-83-9] (Vol. 41, Suppl. 7, Vol. 71;
1999)
Methyl tert-butyl ether [1634-04-4] (Vol. 73;
1999)
Methyl carbamate [598-55-0] (Vol. 12, Suppl. 7; 1987)
Methyl chloride [74-87-3] (Vol. 41, Suppl. 7, Vol. 71;
1999)
1-Methylchrysene [3351-28-8] (Vol. 32, Suppl. 7, Vol.
92; in preparation)
2-Methylchrysene [3351-32-4] (Vol. 32, Suppl. 7, Vol.
92; in preparation)
3-Methylchrysene [3351-31-3] (Vol. 32, Suppl. 7, Vol.
92; in preparation)
4-Methylchrysene [3351-30-2] (Vol. 32, Suppl. 7, Vol.
92; in preparation)
6-Methylchrysene [1705-85-7] (Vol. 32, Suppl. 7, Vol.
92; in preparation)
N-Methyl-N,4-dinitrosoaniline [99-80-9]
(Vol. 1, Suppl. 7; 1987)
4,4'-Methylenediphenyl diisocyanate [101-68-8] (Vol.
19, Suppl. 7, Vol. 71; 1999)
2-Methylfluoranthene [33543-31-6] (Vol. 32, Suppl. 7,
Vol. 92; in preparation)
3-Methylfluoranthene [1706-01-0] (Vol. 32, Suppl. 7,
Vol. 92; in preparation)
Methylglyoxal [78-98-8] (Vol. 51; 1991)
Methyl iodide [74-88-4] (Vol. 41, Suppl. 7, Vol. 71;
1999)
Methyl methacrylate [80-62-6] (Vol. 60; 1994)
N-Methylolacrylamide [90456-67-0] (Vol. 60; 1994)
Methyl parathion [298-00-0] (Vol. 30, Suppl. 7; 1987)
1-Methylphenanthrene [832-69-9] (Vol. 32, Suppl. 7, Vol.
92; in preparation)
7-Methylpyrido[3,4-c]psoralen [85878-63-3] (Vol.
40, Suppl.7; 1987)
Methyl red [493-52-7] (Vol. 8, Suppl. 7; 1987)
Methyl selenac [144-34-3] (Vol. 12, Suppl. 7; 1987)
Microcystis extracts (Vol. 94; in preparation)
Modacrylic fibres (Vol. 19, Suppl. 7; 1987)
Monuron [150-68-5] (Vol. 53; 1991)
Morpholine [110-91-8] (Vol. 47, Vol. 71; 1999)
Musk ambrette [83-66-9] (Vol. 65; 1996)
Musk xylene [81-15-2] (Vol. 65; 1996)
1,5-Naphthalenediamine [2243-62-1] (Vol. 27, Suppl. 7;
1987)
1,5-Naphthalene diisocyanate [3173-72-6] (Vol. 19, Suppl.
7, Vol. 71; 1999)
Naphtho[1,2-b]fluoranthene [111189-32-3] (Vol.
92; in preparation)
Naphtho[2,1-a]fluoranthene [203-20-3] (Vol. 92;
in preparation)
Naphtho[2,3-e]pyrene [193-09-9] (Vol. 92; in preparation)
1-Naphthylamine [134-32-7] (Vol. 4, Suppl. 7; 1987)
1-Naphthylthiourea (ANTU) [86-88-4] (Vol. 30, Suppl.
7; 1987)
Nithiazide [139-94-6] (Vol. 31, Suppl. 7; 1987)
5-Nitro-ortho-anisidine [99-59-2] (Vol. 27, Suppl.
7; 1987)
9-Nitroanthracene [602-60-8] (Vol. 33, Suppl. 7; 1987)
7-Nitrobenz[a]anthracene [20268-51-3] (Vol. 46;
1989)
6-Nitrobenzo[a]pyrene [63041-90-7] (Vol. 46; 1989)
4-Nitrobiphenyl [92-93-3] (Vol. 4, Suppl. 7; 1987)
3-Nitrofluoranthene [892-21-7] (Vol. 33, Suppl. 7; 1987)
Nitrofural (Nitrofurazone) [59-87-0] (Vol. 50; 1990)
Nitrofurantoin [67-20-9] (Vol. 50; 1990)
1-Nitronaphthalene [86-57-7] (Vol. 46; 1989)
2-Nitronaphthalene [581-89-5] (Vol. 46; 1989)
3-Nitroperylene [20589-63-3] (Vol. 46; 1989)
2-Nitropyrene [789-07-1] (Vol. 46; 1989)
N'-Nitrosoanabasine (NAB) [37620-20-5] (Vol. 37,
Suppl. 7, Vol. 89; 2007)
N'-Nitrosoanatabine (NAT) [71267-22-6] (Vol. 37,
Suppl. 7, Vol. 89; 2007)
N-Nitrosodiphenylamine [86-30-6] (Vol. 27, Suppl.
7; 1987)
para-Nitrosodiphenylamine [156-10-5] (Vol. 27,
Suppl. 7; 1987)
N-Nitrosofolic acid [29291-35-8] (Vol. 17, Suppl.
7; 1987)
N-Nitrosoguvacine [55557-01-2] (Vol. 85; 2004)
N-Nitrosoguvacoline [55557-02-3] (Vol. 85; 2004)
N-Nitrosohydroxyproline [30310-80-6] (Vol. 17,
Suppl. 7; 1987)
3-(N-Nitrosomethylamino)propionaldehyde [85502-23-4]
(Vol. 85; 2004)
N-Nitrosoproline [7519-36-0] (Vol. 17, Suppl.
7; 1987)
Nitrotoluenes [88-72-2; 99-08-1; 99-99-0] (Vol. 65; 1996)
5-Nitro-ortho-toluidine [99-55-8] (Vol. 48; 1990)
Nitrovin [804-36-4] (Vol. 31, Suppl. 7; 1987)
Nodularins [118399-22-7] (Vol. 94; in preparation)
Nylon 6 [25038-54-4] (Vol. 19, Suppl. 7; 1987)
Oestradiol mustard [22966-79-6] (Vol. 9, Suppl. 7; 1987)
Opisthorchis felineus (infection with) (Vol. 61;
1994)
Orange I [523-44-4] (Vol. 8, Suppl. 7; 1987)
Orange G [1936-15-8] (Vol. 8, Suppl. 7; 1987)
Oxyphenbutazone [129-20-4] (Vol. 13, Suppl. 7; 1987)
Palygorskite (attapulgite) [12174-11-7] (short fibres,
< 5 micrometres) (Vol. 68; 1997)
Paracetamol (Acetaminophen) [103-90-2] (Vol. 73; 1999)
Parasorbic acid [10048-32-5] (Vol. 10, Suppl. 7; 1987)
Parathion [56-38-2] (Vol. 30, Suppl. 7; 1987)
Patulin [149-29-1] (Vol. 40, Suppl. 7; 1987)
Penicillic acid [90-65-3] (Vol. 10, Suppl. 7; 1987)
Pentachloroethane [76-01-7] (Vol. 41, Suppl. 7, Vol.
71; 1999)
Permethrin [52645-53-1] (Vol. 53; 1991)
Perylene [198-55-0] (Vol. 32, Suppl. 7, Vol. 92; in preparation)
Petasitenine [60102-37-6] (Vol. 31, Suppl. 7; 1987)
Phenanthrene [85-01-8] (Vol. 32, Suppl. 7, Vol. 92; in
preparation)
Phenelzine sulfate [156-51-4] (Vol. 24, Suppl. 7; 1987)
Phenicarbazide [103-03-7] (Vol. 12, Suppl. 7; 1987)
Phenol [108-95-2] (Vol. 47, Vol. 71; 1999)
Phenylbutazone [50-33-9] (Vol. 13, Suppl. 7; 1987)
meta-Phenylenediamine [108-45-2] (Vol. 16, Suppl.
7; 1987)
para-Phenylenediamine [106-50-3] (Vol. 16, Suppl.
7; 1987)
N-Phenyl-2-naphthylamine [135-88-6] (Vol. 16,
Suppl. 7;1987)
ortho-Phenylphenol [90-43-7] (Vol. 73; 1999)
Picene [213-46-7] (Vol. 92; in preparation)
Picloram [1918-02-1] (Vol. 53; 1991)
Piperonyl butoxide [51-03-6] (Vol. 30, Suppl. 7; 1987)
Polyacrylic acid [9003-01-4] (Vol. 19, Suppl. 7; 1987)
Polychlorinated dibenzo-para-dioxins (other than
2,3,7,8-tetrachlorodibenzo-para-dioxin) (Vol. 69;
1997)
Polychlorinated dibenzofurans (Vol. 69; 1997)
Polychloroprene [9010-98-4] (Vol. 19, Suppl. 7; 1987)
Polyethylene [9002-88-4] (Vol. 19, Suppl. 7; 1987)
Polymethylene polyphenyl isocyanate [9016-87-9] (Vol.
19, Suppl.7; 1987)
Polymethyl methacrylate [9011-14-7] (Vol. 19, Suppl.
7; 1987)
Polypropylene [9003-07-0] (Vol. 19, Suppl. 7; 1987)
Polystyrene [9003-53-6] (Vol. 19, Suppl. 7; 1987)
Polytetrafluoroethylene [9002-84-0] (Vol. 19, Suppl.
7; 1987)
Polyurethane foams [9009-54-5] (Vol. 19, Suppl. 7; 1987)
Polyvinyl acetate [9003-20-7] (Vol. 19, Suppl. 7; 1987)
Polyvinyl alcohol [9002-89-5] (Vol. 19, Suppl. 7; 1987)
Polyvinyl chloride [9002-86-2] (Vol. 19, Suppl. 7; 1987)
Polyvinyl pyrrolidone [9003-39-8] (Vol. 19, Suppl. 7,
Vol. 71; 1999)
Ponceau SX [4548-53-2] (Vol. 8, Suppl. 7; 1987)
Potassium bis(2-hydroxyethyl)dithiocarbamate [23746-34-1]
(Vol. 12, Suppl. 7; 1987)
Prazepam [2955-38-6] (Vol. 66; 1996)
Prednimustine [29069-24-7] (Vol. 50; 1990)
Prednisone [53-03-2] (Vol. 26, Suppl. 7; 1987)
Proflavine salts (Vol. 24, Suppl. 7; 1987)
Pronetalol hydrochloride [51-02-5] (Vol. 13, Suppl. 7;
1987)
Propham [122-42-9] (Vol. 12, Suppl. 7; 1987)
n-Propyl carbamate [627-12-3] (Vol. 12, Suppl.
7; 1987)
Propylene [115-07-1] (Vol. 60; 1994)
Ptaquiloside [87625-62-5] (Vol. 40, Suppl. 7; 1987)
Pyrene [129-00-0] (Vol. 32, Suppl. 7, Vol. 92; in preparation)
Pyridine [110-86-1] (Vol. 77; 2000)
Pyrido[3,4-c]psoralen [85878-62-2] (Vol. 40, Suppl.
7; 1987)
Pyrimethamine [58-14-0] (Vol. 13, Suppl. 7; 1987)
Quercetin [117-39-5] (Vol. 73; 1999)
para-Quinone [106-51-4] (Vol. 15, Suppl. 7, Vol.
71; 1999)
Quintozene (Pentachloronitrobenzene) [82-68-8] (Vol.
5, Suppl. 7; 1987)
Reserpine [50-55-5] (Vol. 24, Suppl. 7; 1987)
Resorcinol [108-46-3] (Vol. 15, Suppl. 7, Vol. 71, 1999)
Retrorsine [480-54-6] (Vol. 10, Suppl. 7; 1987)
Rhodamine B [81-88-9] (Vol. 16, Suppl. 7; 1987)
Rhodamine 6G [989-38-8] (Vol. 16, Suppl. 7; 1987)
Rifampicin [13292-46-1] (Vol. 24, Suppl. 7; 1987)
Ripazepam [26308-28-1] (Vol. 66; 1996)
Rock (stone) wool (Vol. 43, Vol. 81; 2002)
Rugulosin [23537-16-8] (Vol. 40, Suppl. 7; 1987)
Saccharated iron oxide [8047-67-4] (Vol. 2, Suppl. 7;
1987)
Saccharin [81-07-2] and its salts (Vol. 73; 1999)
(NB: Overall evaluation downgraded from 2B to 3 with supporting
evidence from other relevant data)
Scarlet Red [85-83-6] (Vol. 8, Suppl. 7; 1987)
Schistosoma mansoni (infection with) (Vol. 61;
1994)
Selenium [7782-49-2] and selenium compounds (Vol. 9,
Suppl. 7; 1987)
Semicarbazide hydrochloride [563-41-7] (Vol. 12, Suppl.
7; 1987)
Seneciphylline [480-81-9] (Vol. 10, Suppl. 7; 1987)
Senkirkine [2318-18-5] (Vol. 31, Suppl. 7; 1987)
Sepiolite [15501-74-3] (Vol. 68; 1997)
Shikimic acid [138-59-0] (Vol. 40, Suppl. 7; 1987)
Silica [7631-86-9], amorphous (Vol. 68; 1997)
Simazine [122-34-9] (Vol. 73; 1999)
Slag wool (Vol. 43, Vol. 81; 2002)
Sodium chlorite [7758-19-2] (Vol. 52; 1991)
Sodium diethyldithiocarbamate [148-18-5] (Vol. 12, Suppl.
7; 1987)
Spironolactone [52-01-7] (Vol. 79; 2001)
Styrene-acrylonitrile copolymers [9003-54-7] (Vol. 19,
Suppl.7; 1987)
Styrene-butadiene copolymers [9003-55-8] (Vol. 19, Suppl.
7; 1987)
Succinic anhydride [108-30-5] (Vol. 15, Suppl. 7; 1987)
Sudan I [842-07-9] (Vol. 8, Suppl. 7; 1987)
Sudan II [3118-97-6] (Vol. 8, Suppl. 7; 1987)
Sudan III [85-86-9] (Vol. 8, Suppl. 7; 1987)
Sudan Brown RR [6416-57-5] (Vol. 8, Suppl. 7; 1987)
Sudan Red 7B [6368-72-5] (Vol. 8, Suppl. 7; 1987)
Sulfafurazole (Sulfisoxazole) [127-69-5] (Vol. 24, Suppl.
7; 1987)
Sulfamethazine [57-68-1] (Vol. 79; 2001)
(NB: Overall evaluation downgraded from 2B to 3 with supporting
evidence from other relevant data)
Sulfamethoxazole [723-46-6] (Vol. 79; 2001)
Sulfites (Vol. 54; 1992)
Sulfur dioxide [7446-09-5] (Vol. 54; 1992)
Sunset Yellow FCF [2783-94-0] (Vol. 8, Suppl. 7; 1987)
Surgical implants and other foreign bodies (Vol. 74;
1999):
- Organic polymeric materials (as a group)
- Orthopaedic implants of complex composition
- Cardiac pacemakers
- Silicone breast implants
- Implanted foreign bodies of metallic chromium or titanium
and of cobalt-based, chromium-based and titanium-based
alloys, stainless steel and depleted uranium
- Dental materials
- Ceramic implants
Symphytine [22571-95-5] (Vol. 31, Suppl. 7; 1987)
Talc [14807-96-6], not containing asbestiform fibres
(inhaled) (Vol. 42, Suppl. 7, Vol. 93; in preparation)
Tannic acid [1401-55-4] and tannins (Vol. 10, Suppl.
7; 1987)
Temazepam [846-50-4] (Vol. 66; 1996)
2,2',5,5'-Tetrachlorobenzidine [15721-02-5] (Vol. 27,
Suppl. 7; 1987)
1,1,1,2-Tetrachloroethane [630-20-6] (Vol. 41, Suppl.
7, Vol. 71; 1999)
1,1,2,2-Tetrachloroethane [79-34-5] (Vol. 20, Suppl.
7, Vol. 71; 1999)
Tetrachlorvinphos [22248-79-9] (Vol. 30, Suppl. 7; 1987)
Tetrakis(hydroxymethyl)phosphonium salts (Vol. 48, Vol.
71; 1999)
Theobromine [83-67-0] (Vol. 51; 1991)
Theophylline [58-55-9] (Vol. 51; 1991)
Thiourea [62-56-6] (Vol. 79; 2001)
Thiram [137-26-8] (Vol. 53; 1991)
Toluene [108-88-3] (Vol. 47, Vol. 71; 1999)
Toremifene [89778-26-7] (Vol. 66; 1996)
Toxins derived from Fusarium graminearum, F.
culmorum and F. crookwellense: zearalenone,
deoxynivalenol, nivalenol and fusarenone X (Vol. 56; 1993)
Toxins derived from Fusarium sporotrichioides:
T-2 toxin (Vol. 56; 1993)
Trichlorfon [52-68-6] (Vol. 30, Suppl. 7; 1987)
Trichloroacetic acid [76-03-9] (Vol. 84; 2004)
Trichloroacetonitrile [545-06-2] (Vol. 52, Vol. 71; 1999)
1,1,1-Trichloroethane [71-55-6] (Vol. 20, Suppl. 7, Vol.
71; 1999)
1,1,2-Trichloroethane [79-00-5] (Vol. 52, Vol. 71; 1999)
Triethanolamine [102-71-6] (Vol. 77; 2000)
Triethylene glycol diglycidyl ether [1954-28-5] (Vol.
11, Suppl. 7, Vol. 71; 1999)
Trifluralin [1582-09-8] (Vol. 53; 1991)
4,4',6-Trimethylangelicin [90370-29-9] plus ultraviolet
A radiation (Suppl. 7; 1987)
2,4,5-Trimethylaniline [137-17-7] (Vol. 27, Suppl. 7;
1987)
2,4,6-Trimethylaniline [88-05-1] (Vol. 27, Suppl. 7;
1987)
4,5',8-Trimethylpsoralen [3902-71-4] (Vol. 40, Suppl.
7; 1987)
2,4,6-Trinitrotoluene [118-96-7] (Vol. 65; 1996)
Triphenylene [217-59-4] (Vol. 32, Suppl. 7, Vol. 92;
in preparation)
Tris(aziridinyl)-para-benzoquinone (Triaziquone)
[68-76-8] (Vol. 9, Suppl. 7; 1987)
Tris(1-aziridinyl)phosphine oxide [545-55-1] (Vol. 9,
Suppl. 7; 1987)
2,4,6-Tris(1-aziridinyl)-s-triazine [51-18-3]
(Vol. 9,Suppl. 7; 1987)
Tris(2-chloroethyl) phosphate [115-96-8] (Vol. 48, Vol.
71; 1999)
1,2,3-Tris(chloromethoxy)propane [38571-73-2] (Vol. 15,
Suppl. 7, Vol. 71; 1999)
Tris(2-methyl-1-aziridinyl)phosphine oxide [57-39-6]
(Vol. 9, Suppl. 7; 1987)
Vat Yellow 4 [128-66-5] (Vol. 48; 1990)
Vinblastine sulfate [143-67-9] (Vol. 26, Suppl. 7; 1987)
Vincristine sulfate [2068-78-2] (Vol. 26, Suppl. 7; 1987)
Vinyl chloride-vinyl acetate copolymers [9003-22-9] (Vol.
19, Suppl. 7; 1987)
Vinylidene chloride [75-35-4] (Vol. 39, Suppl. 7, Vol.
71; 1999)
Vinylidene chloride-vinyl chloride copolymers [9011-06-7]
(Vol.19, Suppl. 7; 1987)
Vinylidene fluoride [75-38-7] (Vol. 39, Suppl. 7, Vol.
71; 1999)
N-Vinyl-2-pyrrolidone [88-12-0] (Vol. 19, Suppl.
7, Vol. 71; 1999)
Vinyl toluene [25013-15-4] (Vol. 60; 1994)
Vitamin K [12001-79-5] substances (Vol. 76; 2000)
Wollastonite [13983-17-0] (Vol. 68; 1997)
Xylenes [1330-20-7] (Vol. 47, Vol. 71; 1999)
2,4-Xylidine [95-68-1] (Vol. 16, Suppl. 7; 1987)
2,5-Xylidine [95-78-3] (Vol. 16, Suppl. 7; 1987)
Yellow AB [85-84-7] (Vol. 8, Suppl. 7; 1987)
Yellow OB [131-79-3] (Vol. 8, Suppl. 7; 1987)
Zectran [315-18-4] (Vol. 12, Suppl. 7; 1987)
Zeolites [1318-02-1] other than erionite (clinoptilolite,
phillipsite,mordenite, non-fibrous Japanese zeolite, synthetic
zeolites) (Vol.68; 1997)
Zineb [12122-67-7] (Vol. 12, Suppl. 7; 1987)
Ziram [137-30-4] (Vol. 53; 1991)
Mixtures
Bitumens [8052-42-4], steam-refined, cracking-residue
and air-refined (Vol. 35, Suppl. 7; 1987)
Crude oil [8002-05-9] (Vol. 45; 1989)
Diesel fuels, distillate (light) (Vol. 45; 1989)
Fuel oils, distillate (light) (Vol. 45; 1989)
Jet fuel (Vol. 45; 1989)
Mate (Vol. 51; 1991)
Mineral oils, highly-refined (Vol. 33, Suppl. 7; 1987)
Petroleum solvents (Vol. 47; 1989)
Printing inks (Vol. 65; 1996)
Tea (Vol. 51; 1991)
Terpene polychlorinates (Strobane®) [8001-50-1]
(Vol. 5, Suppl. 7; 1987)
Exposure circumstances
Calcium carbide production (Vol. 92; in preparation)
Flat-glass and specialty glass (manufacture of) (Vol.
58; 1993)
Hair colouring products (personal use of) (Vol. 57, Vol.
99; in preparation)
Leather goods manufacture (Vol. 25, Suppl. 7; 1987)
Leather tanning and processing (Vol. 25, Suppl. 7; 1987)
Lumber and sawmill industries (including logging) (Vol.
25, Suppl.7; 1987)
Paint manufacture (occupational exposure in) (Vol. 47;
1989)
Pulp and paper manufacture (Vol. 25, Suppl. 7; 1987)
Last updated: 28 March 2008
